[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

November 2016 - July 1883

Decade

Year

Issue

June 5, 2013, Vol 309, No. 21, Pages 2183-2284

This Week in JAMA

This Week in JAMA

Abstract Full Text
free access
JAMA. 2013;309(21):2183-2183. doi:10.1001/jama.2013.5826
Viewpoint

The Morality of Using Mortality as a Financial IncentiveUnintended Consequences and Implications for Acute Hospital Care

Abstract Full Text
JAMA. 2013;309(21):2213-2214. doi:10.1001/jama.2013.5009

The Future of Quality Measurement for Improvement and Accountability

Abstract Full Text
JAMA. 2013;309(21):2215-2216. doi:10.1001/jama.2013.4929

Synthesizing EvidenceShifting the Focus From Individual Studies to the Body of Evidence

Abstract Full Text
JAMA. 2013;309(21):2217-2218. doi:10.1001/jama.2013.5616

Opioid Analgesics—Risky Drugs, Not Risky Patients

Abstract Full Text
JAMA. 2013;309(21):2219-2220. doi:10.1001/jama.2013.5794
A Piece of My Mind

A View From the Safety Net

Abstract Full Text
JAMA. 2013;309(21):2221-2222. doi:10.1001/jama.2013.3443
Original Contribution

Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseThe REDUCE Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2013;309(21):2223-2231. doi:10.1001/jama.2013.5023

In REDUCE (Reduction in the Use of Corticosteroids in Exacerbated COPD), a randomized, noninferiority multicenter trial, Leuppi and coauthors investigate whether a short-term systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional treatment with respect to clinical outcome, and whether it decreases the exposure to steroids and reduces adverse effects. Sin discusses the study findings in an Editorial.

Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis

Abstract Full Text
free access
JAMA. 2013;309(21):2232-2239. doi:10.1001/jama.2013.5827

To determine whether the MUC5B promoter polymorphism is associated with survival in idiopathic pulmonary fibrosis, Peljto and coauthors conducted a retrospective study of survival in 2 independent cohorts of 438 and 148 patients each.

Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and HyperlipidemiaThe Diabetes Surgery Study Randomized Clinical Trial

Abstract Full Text
free access has multimedia
JAMA. 2013;309(21):2240-2249. doi:10.1001/jama.2013.5835

To compare the effect of controlling diabetes risk factors, Ikramuddin and colleagues compared a lifestyle and medical management protocol by assigning 60 of 120 mild to moderately obese patients with diabetes to undergo Roux-en-Y gastric bypass while participating in the protocol.

Editorial

Steroids for Treatment of COPD ExacerbationsLess Is Clearly More

Abstract Full Text
JAMA. 2013;309(21):2272-2273. doi:10.1001/jama.2013.5644

Treating Diabetes With Surgery

Abstract Full Text
JAMA. 2013;309(21):2274-2275. doi:10.1001/jama.2013.4772
Review

Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With DiabetesA Systematic Review

Abstract Full Text
JAMA. 2013;309(21):2250-2261. doi:10.1001/jama.2013.4851

In a systematic review of 54 studies and reviews, Maggard-Gibbons and coauthors assess the association between bariatric surgery vs nonsurgical treatments, and weight loss and glycemic control among patients with diabetes or impaired glucose tolerance and body mass index of 30 to 35.

Grand Rounds

Increasingly Sensitive Assays for Cardiac TroponinsA Review

Abstract Full Text
has expired quiz
JAMA. 2013;309(21):2262-2269. doi:10.1001/jama.2013.5809

To highlight challenges clinicians face when interpreting small elevations of troponin levels in patients with clinical presentations that are not specific for acute coronary syndromes, de Lemos presents the case of a 62-year-old man with elevated troponin levels and discusses the multiple non-ACS etiologies that might account for those elevated levels.

From the JAMA Network

Resuscitation Strategies in Trauma

Abstract Full Text
JAMA. 2013;309(21):2270-2271. doi:10.1001/jama.2013.5161
Research Letter

Retinal Vessel Leakage at High Altitude

Abstract Full Text
free access
JAMA. 2013;309(21):2210-2212. doi:10.1001/jama.2013.5550
Medical News and Perspectives

Addiction: White House Seeks “Third Way”Policy Emphasizes Prevention, Treatment, Recovery

Abstract Full Text
JAMA. 2013;309(21):2201-2202. doi:10.1001/jama.2013.6001

Zolpidem-Related Surge in Emergency Department Visits

Abstract Full Text
JAMA. 2013;309(21):2203-2203. doi:10.1001/jama.2013.6289
Letters

Maternal Folic Acid Supplementation and Risk of Autism

Abstract Full Text
JAMA. 2013;309(21):2208-2208. doi:10.1001/jama.2013.4876

Maternal Folic Acid Supplementation and Risk of Autism—Reply

Abstract Full Text
JAMA. 2013;309(21):2208-2208. doi:10.1001/jama.2013.4879

Meta-analyses of Hydroxyethyl Starch for Volume Resuscitation

Abstract Full Text
JAMA. 2013;309(21):2209-2209. doi:10.1001/jama.2013.5817

Meta-analyses of Hydroxyethyl Starch for Volume Resuscitation—Reply

Abstract Full Text
JAMA. 2013;309(21):2209-2209. doi:10.1001/jama.2013.5820

Ethics of Parsimonious Medicine

Abstract Full Text
JAMA. 2013;309(21):2209-2210. doi:10.1001/jama.2013.5570

Ethics of Parsimonious Medicine—Reply

Abstract Full Text
JAMA. 2013;309(21):2209-2210. doi:10.1001/jama.2013.5573
From JAMA's Daily News Site

Selections From News@JAMA and JAMA Forum

Abstract Full Text
JAMA. 2013;309(21):2203-2203. doi:10.1001/jama.2013.6396
Lab, Field, and Clinic

Technique That Turns Brain Transparent Allows Probing of Intact Neural Circuitry

Abstract Full Text
JAMA. 2013;309(21):2204-2204. doi:10.1001/jama.2013.4961
Lab Reports

Shining a Light on the Brain

Abstract Full Text
JAMA. 2013;309(21):2205-2205. doi:10.1001/jama.2013.5956

Stem Cells to Treat Epilepsy

Abstract Full Text
JAMA. 2013;309(21):2205-2205. doi:10.1001/jama.2013.6698

Targeting Leukemia Stem Cells

Abstract Full Text
JAMA. 2013;309(21):2205-2205. doi:10.1001/jama.2013.6701

Liver Disease Treatments

Abstract Full Text
JAMA. 2013;309(21):2205-2205. doi:10.1001/jama.2013.6702
News From the Centers for Disease Control and Prevention

Some Streets Aren’t Made for Walking

Abstract Full Text
JAMA. 2013;309(21):2206-2206. doi:10.1001/jama.2013.6021

Campylobacter, Vibrio Infections Increased in 2012

Abstract Full Text
JAMA. 2013;309(21):2206-2207. doi:10.1001/jama.2013.5909

Guidance Needed in Newborn Screening for Congenital Heart Defects

Abstract Full Text
JAMA. 2013;309(21):2207-2207. doi:10.1001/jama.2013.6024

NIOSH Warns of Nanomaterials’ Health Risks

Abstract Full Text
JAMA. 2013;309(21):2207-2207. doi:10.1001/jama.2013.6027
The Cover

The Fish Bucket

Abstract Full Text
JAMA. 2013;309(21):2190-2190. doi:10.1001/jama.2013.1599
Poetry and Medicine

After the Fall

Abstract Full Text
JAMA. 2013;309(21):2191-2191. doi:10.1001/jama.2012.233593
JAMA Patient Page

Ear Problems in Children

Abstract Full Text
free access
JAMA. 2013;309(21):2284-2284. doi:10.1001/jama.2013.4428
JAMA Masthead

About This Journal

Abstract Full Text
JAMA. 2013;309(21):2185-2186. doi:10.1001/jama.309.21.2185
JAMA 100 Years Ago

PURE FOOD WELL COOKED

Abstract Full Text
JAMA. 2013;309(21):2192-2195. doi:10.1001/jama.2012.174862
×